Ganaxolone, a positive allosteric modulator of GABAa and synthetic analog of allopregnanolone, acts on a well-characterized synaptic and extrasynaptic target known for antiepileptic (anti-seizure), anxiolytic (anti-anxiety), and anti-depressive activity.
Marinus is developing three different convenient dose forms of ganaxolone—IV, capsule, and liquid—to maximize the therapeutic reach to adult and pediatric patients in both acute and chronic care settings.
| Product Name |
Ganaxolone |
| CAS Number |
38398-32-2 |
| Therapeutic Class |
Neuroactive Steroid |
| Dosage Form |
Oral capsule and liquid, Injection |
| Availability |
Under Evaluation |
| Regulatory Status |
|